Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 1997

View Archived Issues

HRT inhibits ACE in postmenopausal women

HRT indicated in hypertensive women

Peptide antibiotic isolated from human psoriatic skin

Tularik and Roche Bioscience collaborate on antiinflammatory drug discovery

Cambridge NeuroScience awarded SBIR grant for cancer research

Synsorb Biotech begins phase III trial for Synsorb Pk

Sparta's oral chemotherapeutic agent enters clinical trials

Microbix receives milestone payment under ThromboClear agreement with Gensia

Joint venture established for transgenic ATIII

R&D at Teikoku Hormone

Novel antiarthritic drug in development at P&U

Selective neuropeptide Y5 receptor antagonists described by Synaptic

NPY antagonists from Thomae

Dura: Q2 1997 highlights

Piperidone and glutarimide neurokinin antagonists developed at Pfizer

DepoTech: Q2 1997 highlights

U.K. university researchers develop new agents for AD

FDA health advisory for Accolate

In vitro activity of new glycopeptide from Lilly

Gatifloxacin: in vitro activity, pharmacokinetics and clinical results

Genetics Institute's growth factor recommended for approval by advisory committee

Antibacterial activity, drug interactions and safety of Bay-12-8039

Yuhan presents new parenteral cephalosporin

Diabetes classification not as clear-cut as previously thought

Pharmacia & Upjohn Japanese pipeline in review

Marketing approval sought for Periostat in Italy

Infant nutrition as a way of preventing IDDM

New approaches to the pharmacological treatment of obesity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...